David M. Knott Jr’s GSK GSK Stock Holding History

David M. Knott Jr’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-65,000	Closed	-$2.66M	–	92
2024 Q3	$2.66M	Hold	65,000	–	–	0.93%	23
2024 Q2	$2.5M	Hold	65,000	–	–	1%	20
2024 Q1	$2.79M	Hold	65,000	–	–	0.99%	20
2023 Q4	$2.41M	Hold	65,000	–	–	0.92%	18
2023 Q3	$2.36M	Hold	65,000	–	–	0.9%	19
2023 Q2	$2.32M	Hold	65,000	–	–	0.92%	23
2023 Q1	$2.31M	Buy	65,000 +5,000	+8%	+$175K	0.91%	22
2022 Q4	$2.11M	Buy	60,000 +20,000	+50%	+$666K	0.8%	29
2022 Q3	$1.18M	Buy	+40,000	New	+$1.52M	0.5%	44

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

David M. Knott Jr's GSK Position: Q4 2024 in Review

David M. Knott Jr sold out of GSK (GSK) in Q4 2024, closing a stake of 65,000 shares — an estimated $2.66M sold.

David M. Knott Jr first reported a position in GSK in Q3 2022 and held it in 9 quarters. The position peaked at $2.79M in Q1 2024. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

David M. Knott Jr reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
David M. Knott Jr sold 65,000 GSK shares in Q4 2024, an estimated $2.66M.
David M. Knott Jr first reported a position in GSK in Q3 2022 and held it in 9 quarters.
David M. Knott Jr's GSK position peaked at $2.79M in Q1 2024.
849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on David M. Knott Jr's 13F filing for Q4 2024, filed 12 Feb 2025.